Search Results 531-540 of 12454 for Sertraline

1. Mayo Clinic

   Home · C difficile infection marketing campaign - landing - video ...

2. Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures - Mayo Clinic

   Assessment of long-term safety and efficacy of oral lacosamide (LCM) as an adjunctive therapy for uncontrolled primary generalized tonic-clonic (PGTC) seizures ...

3. Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism - Mayo Clinic

   About this study. This is a Phase 1b, double-blind (Principal Investigators, study subjects, Sponsor, Academic Research Organization ARO and Clinical ...

4. New Mast Cell Lines from Patients with Systemic Mastocytosis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome - Mayo Clinic

   This is a multicenter, double-blind, parallel-group, placebo-controlled, study to assess the efficacy, safety, and PK of ZX008 when used as adjunctive therapy ...

6. Ethinyl estradiol and etonogestrel (vaginal route) - Mayo Clinic

   Etonogestrel and ethinyl estradiol combination is used to prevent pregnancy. It is a flexible birth control vaginal ring that contains two types of hormones, ...

7. Mayo Clinic

   Types of integrative medicine in use at Mayo Clinic include mindfulness and other mind body therapies, herbal supplements, massage, acupuncture, aroma therapy, ...

8. A Study to Create a Biobank of Fallopian Tube Organoids (Small, Simplified Organs) in Women Undergoing Salpingectomy (Surgical Removal of the Fallopian Tubes) - Mayo Clinic

   The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will ...

9. Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients with Advanced Cancers - Mayo Clinic

   This is a Phase 1/2, open-label, dose-escalation, dose-expansion study for the treatment of patients with advanced cancers. Eligible patients with DLBCL or ...

10. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...